Skip to content
Home/Companies/Biotech/Refoxy Pharmaceuticals
Refoxy Pharmaceuticals

Refoxy Pharmaceuticals

Biotech·Germany·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Refoxy Pharmaceuticals?

Refoxy Pharmaceuticals is currently owned by Apollo Health Ventures through Apollo Health Ventures Fund I (2018 vintage), since 2020. Across its history, Refoxy Pharmaceuticals has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-07-03

Apollo Health Ventures
Most recent investor
Apollo Health Ventures
Apollo Health Ventures Fund I · 2018 · Evergreen
2 ownership periods · full history below

Key facts

HQGermany
SectorBiotech
StatusActive
Websitewww.refoxy.com

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Apollo Health Ventures and Boehringer Ingelheim Venture Fund since 2020.
Co-invest · 2 holders · 2020 · present
Apollo Health Ventures
Apollo Health VenturesActive
2020 · present(6yr) · Apollo Health Ventures Fund I · 2018 · Evergreen
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture FundActive
2024 · present(2yr) · Boehringer Ingelheim Venture Fund · 2010 · Evergreen

More from Apollo Health Ventures Fund I

Other portfolio companies in the same fund.

Aeovian Pharmaceuticals
Aeovian Pharmaceuticals
Active
BiotechUS· 2019
Samsara Therapeutics
Samsara Therapeutics
Active
BiotechUK· 2019

More Apollo Health Ventures portfolio companies

From the same investor, across funds.

Therini Bio
Therini Bio
Active
BiotechUS· 2025
Booster Therapeutics
Active
BiotechGermany· 2024
Auron Therapeutics
Auron Therapeutics
Active
BiotechUS· 2022
Cleara Biotech
Cleara Biotech
Active
BiotechNetherlands· 2022
Focal Biosciences
Focal Biosciences
Active
BiotechSwitzerland· 2022
Bloom Science
Bloom Science
Active
BiotechUS· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Refoxy Pharmaceuticals

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Refoxy Pharmaceuticals?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Refoxy Pharmaceuticals.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue